Cours Pandion Therapeutics, Inc.
Actions
PAND
US6983401067
Recherche biotechnologique et médicale
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Gregg Beloff
DFI | Director of Finance/CFO | 56 | - |
Chief Tech/Sci/R&D Officer | - | 01/06/17 | |
John Sundy
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/05/20 |
Varia. 1 janv. | Capi. | |
---|---|---|
-2,31% | 103 Md | |
+0,56% | 95,28 Md | |
+1,69% | 22,15 Md | |
-17,37% | 21,02 Md | |
-9,30% | 18,15 Md | |
-41,01% | 16,73 Md | |
-14,85% | 16,05 Md | |
+3,21% | 13,68 Md | |
+33,54% | 12,17 Md |